News 17 Jun 2026 DNDi and Medicines for Malaria Venture (MMV) pool regulatory expertise to accelerate access to lifesaving medicines
Stories 17 Jun 2026 The DNDi-MMV Joint Regulatory Platform: ‘a pioneering programme project for non-profit medical research organizations to speak with one voice’
Press Releases Translations 12 Jun 2026 La RDC approuve l’utilisation de l’acoziborole, un traitement oral à dose unique contre la maladie du sommeil
Press releases 12 Jun 2026 DRC approves the use of acoziborole, a breakthrough one-day oral treatment against sleeping sickness
Statements 9 Jun 2026 DNDi Statement at the UN Multi-Stakeholder Hearing on Pandemic Prevention, Preparedness, and Response (PPPR)
Press releases 8 Jun 2026 DNDi, GARDP, and MMV join forces to accelerate drug development for patients in greatest need
Scientific articles 5 Jun 2026 Severe visceral leishmaniasis in Ethiopia: Outcomes, co-infections and mortality in a prospective real-world cohort PLOS Neglected Tropical Diseases
Scientific articles 29 May 2026 From invisibility to political power: Policy lessons from a decade of Brazil’s Social Forum for Infectious and Neglected Diseases PLOS Neglected Tropical Diseases
Scientific articles 14 May 2026 In vitro profiling of Trypanosoma cruzi inhibitors identified from high throughput screening and application to parasite painting International Journal for Parasitology: Drugs and Drug Resistance
Statements 15 May 2026 DNDi statement on hantavirus outbreak: ‘Investment in pandemic preparedness efforts remains insufficient.’
Scientific articles 13 May 2026 Chemical genetics reveals Leishmania KKT2 and CRK9 kinase activity is required for cell cycle progression PLOS Pathogens
Press releases 12 May 2026 DNDi welcomes GHIT support for global evaluation and registration of fosravuconazole for eumycetoma, in collaboration with Eisai
In the media 29 Apr 2026 Thailand approves ravidasvir, a new drug for hepatitis C, increasing chances of complete cure Thai Rath
News 6 Jun 2016 Ensuring sustained incentives for pharmaceutical companies to develop medicine for the poor
News 27 May 2016 DNDi delivers statement about CEWG on R&D Financing and Coordination at 69th World Health Assembly
News 13 Apr 2016 Hepatitis C: Current barriers to treat patients and DNDi’s R&D strategy to address urgent needs
News 31 Mar 2016 GHIT invests in GeneDesign and DNDi partnership to develop a better treatment for cutaneous leishmaniasis
News 4 Mar 2016 World Lymphedema Day Designated by US Senate: Will Raise Awareness of 40 Million Suffering from Elephantiasis
News 24 Feb 2016 Portfolio Development: New diseases and new chemical entity enter DNDi project portfolio
